Solidago virgaurea
Botanicalexperimental
Solidago virgaurea, the European goldenrod or woundwort, is an herbaceous perennial plant of the family Asteraceae. It is widespread across most of Europe as well as North Africa and northern, central, and southwestern Asia. It is grown as a garden flower with many different cultivars. It flowers profusely in late summer. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 12, 2018 (NCT04338477)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSolidago virgaurea ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04338477 | Phase 3 | Feb 12, 2018 | Bioforce AG |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bioforce AG | For profit | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1